Company: ASGN
Filing Date: 2025-04-11
Form Type: PRE 14A
Source: 0000890564-25-000017
Chunk: 38

Company: ASGN Inc
Filing Date: 2025-04-11
Form: PRE 14A
Chunk 38
---
 percent of the dollar-denominated value of their target annual equity grant in RSUs. These awards vest in three equal, annual installments on each of January 2, 2025, 2026 and 2027, subject to the executives' continued service to the Company through each such date (except in the case of certain qualifying terminations of employment in connection with a change in control of the Company as discussed in more detail in "Payments upon Termination or Change in Control" below).

PSUs

The remainder of each executive's 2024 grant was delivered as PSUs which vest upon achievement of the average of three years of NOPAT growth over a three-year performance period, with the potential for positive or negative adjustment based on the Company's TSR over the performance period relative to the comparator group outlined below. NOPAT, which is a non-GAAP (U.S. Generally Accepted Accounting Principles) financial measure, is generally calculated as GAAP net operating income as adjusted for non-GAAP items including depreciation, amortization, stock-based compensation, acquisition, foreign exchange rate fluctuations, certain litigation/legal costs, integration and strategic planning expenses, and adjustments eliminating the impact from acquisitions or dispositions during the year. The PSUs will be eligible to vest on December 31, 2026 subject to achievement of the performance targets as follows, and subject to the executives' continued service (except in the case of certain qualifying terminations of employment and/or in connection with a change in control of the Company as discussed in more detail in "Payments upon Termination or Change in Control" below):

Payout Schedule

| Three-Year Average NOPAT Growth Goals                                                                                       |     |             |     | Relative TSR Modifier                                                                                                                                                                                                                                                                                                    |     |                 |
| NOPAT Growth vs. Prior Year Actual                                                                                          |     | Achievement |     | Relative TSR                                                                                                                                                                                                                                                                                                             |     | Modifier Impact |
| ≥12.0%                                                                                                                      |     | 200%        |     | ≥75thP                                                                                                                                                                                                                                                                                                                   |     | +25%            |
| 2.0%                                                                                                                        |     | 100%        |     | 40th - 60th P                                                                                                                                                                                                                                                                                                            |     | —               |
| (13.5)%                                                                                                                     |     | 50%         |     | ≤25th P                                                                                                                                                                                                                                                                                                                  |     | -25%            |
| <(13.5)%                                                                                                                    |     | —%          |     |                                                                                                                                                                                                                                                                                                                          |     |                 |
| Outcomes relative